Tweet
7:00 PM (ET) - WEDNESDAY, June 24th
Webinar Link: https://event.webcasts.com/starthere...key=73cdfe53ec
Participant Dial-in: 877-407-9221 or 201-689-8597 (NORTH AMERICA ONLY)
One hour of continuing education credit is available for physicians, pharmacists, nursing professionals, and PAs.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of physicians, pharmacists, nursing professionals, PAs, and other members of the healthcare team involved in the management of patients with MS.
OBJECTIVE
Upon completion of this activity, participants should be better able to:
Identify the latest research and clinical information available describing use of disease modifying therapies in patients with MS during the COVID-19 pandemic.
MODERATORS
John F. Kramer, PA-C, Moderator
STMP Neurology
Nashville, TN
Bryan D. Walker, MHS, PA-C, MSCS
Duke University Medical Center
Durham, NC
To view the article click here:
https://cmscscholar.org/wp-content/u...i-COVID-MS.pdf
The COVID-19 pandemic and the use of MS disease-modifying therapies Gavin Giovannoni, Chris Hawkes, Jeannette Lechner-Scott, Michael Levy, Emmanuelle Waubant, Julian Gold
The live webinar is being held on Wednesday, June 24th from 7-8 pm (ET).
To Register:
https://event.webcasts.com/starthere...key=73cdfe53ec
To access the live webinar on the date of the event:
https://event.webcasts.com/starthere...key=73cdfe53ec
Participant Dial-In:
877-407-9221 or 201-689-8597 (NORTH AMERICA ONLY)
Please test your system a few minutes prior to the webinar:
System Test Link: http://webcasts.com/test
For technical support the night of the event, call:
877-407-0626 or 201-689-7835 (NORTH AMERICA ONLY)
This activity is supported by educational grants from Celgene Corporation, EMD Serono, Genentech, and Mallinckrodt Pharmaceuticals.
Webinar Link: https://event.webcasts.com/starthere...key=73cdfe53ec
Participant Dial-in: 877-407-9221 or 201-689-8597 (NORTH AMERICA ONLY)
One hour of continuing education credit is available for physicians, pharmacists, nursing professionals, and PAs.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of physicians, pharmacists, nursing professionals, PAs, and other members of the healthcare team involved in the management of patients with MS.
OBJECTIVE
Upon completion of this activity, participants should be better able to:
Identify the latest research and clinical information available describing use of disease modifying therapies in patients with MS during the COVID-19 pandemic.
MODERATORS
John F. Kramer, PA-C, Moderator
STMP Neurology
Nashville, TN
Bryan D. Walker, MHS, PA-C, MSCS
Duke University Medical Center
Durham, NC
To view the article click here:
https://cmscscholar.org/wp-content/u...i-COVID-MS.pdf
The COVID-19 pandemic and the use of MS disease-modifying therapies Gavin Giovannoni, Chris Hawkes, Jeannette Lechner-Scott, Michael Levy, Emmanuelle Waubant, Julian Gold
The live webinar is being held on Wednesday, June 24th from 7-8 pm (ET).
To Register:
https://event.webcasts.com/starthere...key=73cdfe53ec
To access the live webinar on the date of the event:
https://event.webcasts.com/starthere...key=73cdfe53ec
Participant Dial-In:
877-407-9221 or 201-689-8597 (NORTH AMERICA ONLY)
Please test your system a few minutes prior to the webinar:
System Test Link: http://webcasts.com/test
For technical support the night of the event, call:
877-407-0626 or 201-689-7835 (NORTH AMERICA ONLY)
This activity is supported by educational grants from Celgene Corporation, EMD Serono, Genentech, and Mallinckrodt Pharmaceuticals.